Early access waitlist launching late 2026

We're building AllerNote for the professionals who patch-test, prescribe, and sell skincare.

B2B and API access are pre-launch. Tell us what would actually help, and we'll bring you in the moment it ships. No sales call follow-up unless you ask for one.

  • Direct reply from the founder within 48 hours
  • First in line for early-access invitations
  • Your use-case shapes what we build first
  • No marketing list, no automated sequences
Snehal MaheshwariFounder, AllerNote · reads every submission
Built with

Pre-launch program is open to three groups.

Most-asked group

Dermatologists & patch-test clinics

Send patch-test patients home with more than a printout. Doctor-ready PDF summaries, multi-patient dashboard, secure profile sharing, and referral tracking.

  • PDF allergen handout for every patient
  • Multi-patient dashboard with profile history
  • Read-only profile share links by SMS or email

Estheticians & beauty pros

Pre-check products against your client's allergies before you recommend. Send branded safe-product lists after every facial.

Brands & retailers

API access to our 4k+ product database, white-label ingredient analyzer widgets for your PDPs, and bulk catalog audits.

Roadmap

What we're building. What's still on the drawing board.

Everything below is in scope for the B2B program. Status reflects today.

  1. 01Building now
    Dermatologist handout PDFPre-filled allergen summary, ready to print or email. Available to early-access clinics first.
  2. 02Planned Q3 2026
    REST API accessQuery our 60k+ product and ingredient database directly. INCI lookup, allergen cross-checks, synonym mapping.
  3. 03Planned Q4 2026
    White-label PDP widgetEmbed the ingredient analyzer in your product detail pages. Visitors check their own allergens against your catalog.
  4. 04Researching
    Bulk catalog allergen auditOne-shot report across an entire SKU range. Compliance-ready CSV, flagged INCI matches, suggested reformulations.

The order changes based on what waitlist responses tell us matters most. That's the point of asking.